Arkolith/Insider Trading/MLYS/Form 4

Congleton Jon

Chief Executive Officer, DirectorMineralys Therapeutics, Inc. (MLYS) · full profile →Form 4 · filed Jun 30, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.0M
Net Open-Market Flow
-$2.0M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 30, 2026Sell(S)58K$25.94$1.5M631K
Jun 30, 2026Sell(S)17K$26.82$456K614K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001933414-26-000096) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML